1-tetradecanoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

Term ID

CHEBI:86162

Synonyms

(2R)-2-{[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy}-3-(tetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
1-Myristoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine
1-tetradecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
GPCho(14:0/22:6)
GPCho(14:0/22:6n3)
GPCho(14:0/22:6w3)
PC(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(14:0/22:6)
PC(14:0/22:6n3)
PC(14:0/22:6w3)
Phosphatidylcholine(14:0/22:6)
Phosphatidylcholine(14:0/22:6n3)
Phosphatidylcholine(14:0/22:6w3)

Definition

A phosphatidylcholine 36:6 in which the acyl groups at positions 1 and 2 tetradecanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: phosphatidylcholine 36:6 tetradecanoate ester

phosphatidylcholine 36:6 tetradecanoate ester Show first 5 Terms
has_functional_parent: all-cis-docosa-4,7,10,13,16,19-hexaenoic acid

all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Show first 5 Terms

Phenotype

Phenotype resulting from 1-tetradecanoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

Phenotype where environments contain 1-tetradecanoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

Phenotype modified by environments containing 1-tetradecanoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

Human Disease Model